Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1250
| Despition | Lin28 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1199 | Beta crystallin S Blocking Peptide (AC1199) | 250 µg | inquiry |
| ACPP-1615 | Human CRYBB1 Protein (AC1615) | 5 µg | inquiry |
| ACPP-1678 | Human SDCBP Protein (AC1678) | 5 µg | inquiry |
| ACPP-1628 | Human LIF Protein, GST (AC1628) | 2 µg | inquiry |
| ACPP-1118 | Human Insulin (Active) (AC1118) | 25 mg | inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg | inquiry |
| ACPP-1692 | Human GLUL Protein (AC1692) | 5 µg | inquiry |
| ACPP-1502 | Human DAG1 Protein (AC1502) | 2 µg | inquiry |
| ACPP-1687 | Mouse Visfatin Protein (AC1687) | 5 µg | inquiry |
| ACPP-1014 | Recombinant Human P Cadherin Protein (6×His Tag) (AC1014) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.